
High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
Immunoaffinity column sample clean-up and HPLC post-column photochemical derivatization with fluorescence detection to analyze sflatoxins B1,B2, G1, and G2.





